Brainvectis

Brainvectis

Brainvectis

BrainVectis's goal is to stop the progression of neurodegenerative diseases such as Alzheimer's and Huntington's by restoring brain cholesterol metabolism..
Raised
$1.2M
Follow us
Alexa global traffic share
Latest funding
€1,000,000
Venture capital (Series A) - 2016
Team Size
1–10
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Brainvectis makes some noise.